Icodec insulin cost?

Short answer: Icodec insulin isn’t approved or marketed yet in the U.S. or most other places, so there’s no official price set at this time.

What that means for cost:
- The price will depend on country, regulator approval, and payer negotiations. No list price exists until it’s approved.
- For context, prices of branded basal insulins (like insulin degludec or glargine) vary a lot by country and by insurance. In the U.S., list prices for branded basal insulins are typically several hundred dollars per month, but patients with insurance often pay far less (co-pays or discounts can bring it down to roughly low hundreds or less per month). Exact out-of-pocket costs depend on your plan, manufacturer programs, and pharmacy.
- Globally, prices range widely due to different healthcare systems, subsidies, and reimbursement.

If you want, tell me your country or region and whether you have insurance or a manufacturer program, and I can give a more tailored (but still speculative, since Icodec isn’t approved yet) overview of what the cost might look like and what to check for once it’s approved. I can also help you compare with current insulin options and discuss patient-assistance programs.